Cover Image
Market Research Report

Asia Pacific Clinical Nutrition Market Forecast 2019-2028

Published by Inkwood Research Product code 952507
Published Content info 123 Pages
Delivery time: 2-3 business days
Price
Back to Top
Asia Pacific Clinical Nutrition Market Forecast 2019-2028
Published: August 3, 2020 Content info: 123 Pages
Description

KEY FINDINGS

The Asia Pacific clinical nutrition market is evaluated to grow with a CAGR of 5.75%, during the forecast period of 2019 to 2028. The market growth is primarily fuelled by the rising geriatric population, increasing prevalence of malnutrition, the demand for healthcare infrastructure, and the growing number of hospitals in developing countries.

MARKET INSIGHTS

The Asia Pacific clinical nutrition market growth is assessed across India, Thailand, China, Vietnam, Japan, Australia & New Zealand, South Korea, Indonesia, and the rest of the Asia Pacific. India's clinical nutrition market is projected to witness massive growth over the forecast period. The rising geriatric population, coupled with the growing prevalence of chronic ailments, and medical conditions have led to an accelerated demand for dietary and nutritional supplements within the country. Moreover, the plummeting fertility rate and the decelerated population growth are causing a transition in India's demographic dividend, from a younger populace to the aging. As a result, the surging elderly group is reinforcing the market for clinical nutrition in the country.

Conversely, according to a 2019 government survey, the incidence of diabetes in India accounted for more than 11%, with over 72 million people suffering from the chronic condition. The nation also has one of the highest numbers of malnourished children, which is a critical challenge for human development. For instance, the National Family Health Survey revealed that only two in five women could breastfeed neonates within an hour of birthing, and one out of two women could breastfeed for half a year. Thus, these factors are estimated to propagate the region's market for clinical nutrition.

COMPETITIVE INSIGHTS

Otsuka Holdings Co Ltd, Sichuan Kelun Pharmaceutical Co Ltd, Meiji Holdings Co Ltd, Sanofi, Nestle Health Science, etc., are among the prominent companies in the market.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32936

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING PREVALENCE OF CHRONIC DISEASES AND LIFESTYLE ASSOCIATED DISEASE
    • 3.2.2. RISE IN ELDERLY POPULATION
    • 3.2.3. HIGH OCCURRENCE OF MALNUTRITION AMONG HOSPITALIZED PATIENTS
    • 3.2.4. SURGING DEMAND IN DEVELOPING ECONOMIES
  • 3.3. KEY RESTRAINTS
    • 3.3.1. LACK OF AWARENESS FOR CLINICAL NUTRITION
    • 3.3.2. COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING
    • 3.3.3. STRINGENT REGULATIONS

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY ROUTE OF ADMINISTRATION

  • 5.1. ORAL
  • 5.2. ENTERAL
  • 5.3. PARENTERAL

6. MARKET BY APPLICATION

  • 6.1. CANCER
  • 6.2. NEUROLOGICAL DISEASES
  • 6.3. GASTROINTESTINAL DISORDERS
  • 6.4. METABOLIC DISORDERS
  • 6.5. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. PEDIATRIC
  • 7.2. GERIATRIC
  • 7.3. ADULTS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. ASIA PACIFIC
    • 8.1.1. JAPAN
    • 8.1.2. CHINA
    • 8.1.3. INDIA
    • 8.1.4. AUSTRALIA & NEW ZEALAND
    • 8.1.5. SOUTH KOREA
    • 8.1.6. THAILAND
    • 8.1.7. INDONESIA
    • 8.1.8. VIETNAM
    • 8.1.9. REST OF ASIA PACIFIC

9. COMPANY PROFILES

  • 9.1. ABBOTT LABORATORIES
  • 9.2. AMERICAN REGENT INC
  • 9.3. BASF SE
  • 9.4. BAXTER INTERNATIONAL INC
  • 9.5. B BRAUN
  • 9.6. DANONE
  • 9.7. EXELA PHARMA SCIENCES
  • 9.8. GRIFOLS SA
  • 9.9. LONZA LTD
  • 9.10. MEIJI HOLDINGS CO LTD
  • 9.11. NESTLE HEALTH SCIENCE
  • 9.12. OTSUKA HOLDINGS CO LTD
  • 9.13. RECKITT BENCKISER GROUP PLC
  • 9.14. SANOFI
  • 9.15. SICHUAN KELUN PHARMACEUTICAL CO LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL NUTRITION
  • TABLE 2: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: MAJOR CATEGORIES OF ASIA PACIFIC HEALTH SPENDING, 2017
  • FIGURE 2: COMPLICATIONS OF ENTERAL FEEDING
  • FIGURE 3: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: KEY INVESTMENT INSIGHTS
  • FIGURE 7: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, IN 2019
  • FIGURE 8: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)
  • FIGURE 9: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)
  • FIGURE 10: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)
  • FIGURE 11: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY APPLICATION, IN 2019
  • FIGURE 12: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)
  • FIGURE 13: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)
  • FIGURE 14: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)
  • FIGURE 15: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)
  • FIGURE 16: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
  • FIGURE 17: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY END-USER, IN 2019
  • FIGURE 18: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)
  • FIGURE 19: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)
  • FIGURE 20: ASIA PACIFIC CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)
  • FIGURE 21: ASIA PACIFIC CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 22: JAPAN CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 23: CHINA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 24: INDIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 25: AUSTRALIA & NEW ZEALAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 26: SOUTH KOREA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 27: THAILAND CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 28: INDONESIA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 29: VIETNAM CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 30: REST OF ASIA PACIFIC CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
Back to Top